RAD52: Paradigm of Synthetic Lethality and New Developments
Related Experiment Video
Updated: Oct 10, 2025
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Matthew J Rossi1, Sarah F DiDomenico1, Mikir Patel1
1Department of Biochemistry and Structural Biology, University of Texas Health Science Center, San Antonio, TX, United States.
Abstract:
DNA double-strand breaks and inter-strand cross-links are the most harmful types of DNA damage that cause genomic instability that lead to cancer development. The highest fidelity pathway for repairing damaged double-stranded DNA is termed Homologous recombination (HR). Rad52 is one of the key HR proteins in eukaryotes. Although it is critical for most DNA repair and recombination events in yeast, knockouts of mammalian RAD52 lack any discernable phenotypes. As a consequence, mammalian RAD52 has been long overlooked. That is changing now, as recent work has shown RAD52 to be critical for backup DNA repair pathways in HR-deficient cancer cells. Novel findings have shed light on RAD52's biochemical activities. RAD52 promotes DNA pairing (D-loop formation), single-strand DNA and DNA:RNA annealing, and inverse strand exchange. These activities contribute to its multiple roles in DNA damage repair including HR, single-strand annealing, break-induced replication, and RNA-mediated repair of DNA. The contributions of RAD52 that are essential to the viability of HR-deficient cancer cells are currently under investigation. These new findings make RAD52 an attractive target for the development of anti-cancer therapies against BRCA-deficient cancers.
Insights
Mammalian RAD52 protein is crucial for repairing DNA damage in cancer cells lacking homologous recombination (HR) repair. Targeting RAD52 offers a promising strategy for developing new anti-cancer therapies against HR-deficient tumors.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- DNA double-strand breaks and inter-strand cross-links are severe DNA lesions.
- Genomic instability resulting from DNA damage can lead to cancer.
- Homologous recombination (HR) is the primary high-fidelity DNA repair pathway for double-strand breaks.
Purpose of the Study:
- To investigate the role of RAD52 in DNA repair mechanisms, particularly in mammalian systems.
- To explore the biochemical activities of RAD52 and its involvement in various DNA repair pathways.
- To assess the potential of RAD52 as a therapeutic target in cancer treatment.
Main Methods:
- Biochemical assays to characterize RAD52's DNA repair activities, including DNA pairing (D-loop formation), annealing, and strand exchange.
- Investigation of RAD52's function in different DNA damage repair pathways such as HR, single-strand annealing, and break-induced replication.
- Analysis of RAD52's essentiality in HR-deficient cancer cells.
Main Results:
- RAD52 exhibits multiple biochemical activities, including promoting DNA pairing, annealing of single-stranded DNA and DNA:RNA, and inverse strand exchange.
- These activities enable RAD52 to participate in diverse DNA repair processes.
- RAD52 is found to be critical for the viability of cancer cells with deficiencies in homologous recombination.
Conclusions:
- Mammalian RAD52, previously overlooked, plays a vital role in backup DNA repair pathways, especially in HR-deficient cancer cells.
- RAD52's multifaceted DNA repair functions make it essential for the survival of certain cancer types.
- RAD52 represents a promising therapeutic target for developing novel anti-cancer drugs against BRCA-deficient cancers.
Related Concept Videos
02:37Restarting Stalled Replication Forks
02:55Synthetic Biology
Golden rice
Golden rice is a genetically modified...
02:53Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...